1 of 1
Story summary
- WTA will require all tour players to undergo a genetic sex test.
- The policy takes effect Tuesday and mandates SRY-gene testing via cheek swab, blood or saliva.
- Players who test positive must undergo additional medical assessment before competing.
- Players must sign an agreement acknowledging possible disciplinary action for refusing the test.
- The rule replaces 2024 policy allowing transgender women with testosterone below 2.5 nmol/L and follows standards used by World Athletics.
